Global Monkey Pox Testing Market Size Projected to Reach $1.81 Billion During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Monkey Pox Testing Market Expected To Expand Between 2025 And 2029?

The monkey pox testing market has experienced consistent expansion over recent years. Projections indicate it will grow from $1.46 billion in 2024 to $1.52 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%. The historical growth in this sector can be attributed to augmented government funding and initiatives, a rising demand for rapid diagnostic tests, enhanced testing capabilities, intensified research and development efforts, and expanded public awareness campaigns.

The monkeypox testing market size is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach a valuation of $1.81 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 4.4%. This projected increase is largely due to factors such as increased spending on healthcare, the emergence of point-of-care (POC) testing, the proliferation of at-home testing options, a greater emphasis on making tests accessible and affordable, and enhancements in healthcare infrastructure. Key developments expected during this period encompass the incorporation of testing into surveillance systems, its integration with digital health technologies, ongoing technological progress, its incorporation into broader public health frameworks, and breakthroughs in diagnostic research.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18817&type=smp

Which Major Market Drivers Are Shaping The Future Of The Monkey Pox Testing Market?

The rising occurrence of monkeypox disease is anticipated to boost the expansion of the monkey pox testing market in the future. Monkeypox, an uncommon viral condition, is caused by the monkeypox virus, which belongs to the orthopoxvirus genus and is linked to the smallpox virus. The surge in monkeypox infections can be attributed to heightened human-to-human transmission, international travel, and diminished immunity due to the cessation of smallpox vaccination initiatives. Monkeypox testing is crucial for early identification of infected individuals, facilitating prompt treatment and isolation to curb disease dissemination. It also assists in monitoring outbreaks and comprehending viral transmission dynamics. For example, in May 2022, data from the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government body, revealed 1,152 suspected monkeypox cases between January and April 2022, resulting in 55 fatalities and a case-fatality rate of 4.8%, distributed across 54 health zones in 14 provinces. Additionally, when compared to the corresponding period in 2021, there was an uptick of 138 suspected cases and 14 deaths, leading to a higher case-fatality rate of 10.1%. Consequently, the growing incidence of monkeypox disease is propelling the growth of the monkey pox testing market.

What Are The Major Segments Identified In The Monkey Pox Testing Market?

The monkey pox testingmarket covered in this report is segmented –

1) By Technology: Polymerase Chain Reaction (PCR); Lateral Flow Assay (LFA); Other Technologies

2) By Mode: Laboratory Testing; Point Of Care Testing

3) By End-Use: Hospitals And Clinics; Diagnostic Laboratories; Other End-Uses

Subsegments:

1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR); Reverse Transcription PCR (RT-PCR); Multiplex PCR

2) By Lateral Flow Assay (LFA): Immunochromatographic Lateral Flow Assays; Rapid Antigen Detection Kits

3) By Other Technologies: ELISA (Enzyme-Linked Immunosorbent Assay); CRISPR-based Testing; Serological Tests (Antibody Detection); Nucleic Acid Sequence-Based Amplification (NASBA)

What Long-Term Trends Will Shape The Future Growth Of The Monkey Pox Testing Industry?

Leading companies within the monkey pox testing market are prioritizing the development of advanced diagnostic solutions, such as saliva-based monkey pox testing, to enhance accuracy, convenience, and overall accessibility. Saliva-based monkey pox testing is a diagnostic method that uses saliva samples to detect the presence of the monkeypox virus. For example, in July 2022, Flow Health, a US-based medical laboratory, launched its saliva-based (polymerase chain reaction) PCR test for monkeypox, thereby innovating the testing process by providing a more convenient and non-invasive technique for virus detection. This groundbreaking test is notable for its high sensitivity and specificity, rapid amplification of genetic material, and versatility across various applications. It facilitates both quantitative analysis of viral loads and direct pathogen detection, all while streamlining sample collection. A key advantage of this test is its capability to screen individuals before visible lesions emerge, which is essential for early diagnosis and reducing virus transmission.

Which Leading Companies Dominate The Monkey Pox Testing Market Share?

Major companies operating in the monkey pox testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., Aegis Sciences Corporation, Chembio Diagnostics Inc., Flow Health Inc., SeraCare Life Sciences Inc., BioGX Inc., Applied DNA Sciences Inc., CerTest Biotec S.L., Altona Diagnostics GmbH, Creative Biogene Inc., ACON Biotech (Hangzhou) Co Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Monkey Pox Testing Market?

North America was the largest region in the monkey pox testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Monkey Pox Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18817&type=smp

Browse Through More Reports Similar to the Global Monkey Pox Testing Market 2025, By The Business Research Company

Infection Control Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Infection Control Supplies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report

Infection Prevention Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795